Details

Autor(en) / Beteiligte

• Kuneman, Jurrien H.
• Singh, Gurpreet K.
• Hansson, Nicolaj C.
• Fusini, Laura
• Poulsen, Steen H.
• Fortuni, Federico
• Vollema, E. Mara
• Pedersen, Anders L. D.
• Annoni, Andrea D.
• Nørgaard, Bjarne L.
• Pontone, Gianluca
• Ajmone Marsan, Nina
• Delgado, Victoria
• Bax, Jeroen J.
• Knuuti, Juhani

Titel

Subclinical leaflet thrombosis after transcatheter aortic valve implantation: no association with left ventricular reverse remodeling at 1-year follow-up

Ist Teil von

• The International Journal of Cardiovascular Imaging, 2022-03, Vol.38 (3), p.695-705

Ort / Verlag

Dordrecht: Springer Netherlands

Erscheinungsjahr

2022

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Hypo-attenuated leaflet thickening (HALT) of transcatheter aortic valves is detected on multidetector computed tomography (MDCT) and reflects leaflet thrombosis. Whether HALT affects left ventricular (LV) reverse remodeling, a favorable effect of LV afterload reduction after transcatheter aortic valve implantation (TAVI) is unknown. The aim of this study was to examine the association of HALT after TAVI with LV reverse remodeling. In this multicenter case–control study, patients with HALT on MDCT were identified, and patients without HALT were propensity matched for valve type and size, LV ejection fraction (LVEF), sex, age and time of scan. LV dimensions and function were assessed by transthoracic echocardiography before and 12 months after TAVI. Clinical outcomes (stroke or transient ischemic attack, heart failure hospitalization, new-onset atrial fibrillation, all-cause mortality) were recorded. 106 patients (age 81 ± 7 years, 55% male) with MDCT performed 37 days [IQR 32–52] after TAVI were analyzed (53 patients with HALT and 53 matched controls). Before TAVI, all echocardiographic parameters were similar between the groups. At 12 months follow-up, patients with and without HALT showed a significant reduction in LV end-diastolic volume, LV end-systolic volume and LV mass index (from 125 ± 37 to 105 ± 46 g/m 2 , p = 0.001 and from 127 ± 35 to 101 ± 27 g/m 2 , p < 0.001, respectively, p for interaction = 0.48). Moreover, LVEF improved significantly in both groups. In addition, clinical outcomes were not statistically different. Improvement in LVEF and LV reverse remodeling at 12 months after TAVI were not limited by HALT.